Related Experiment Videos
Persistent hypercalciuria and elevated 25-hydroxyvitamin D3 in children with infantile hypercalcaemia
E Pronicka1, E Rowińska, H Kulczycka
1Department of Metabolic Diseases, Children's Memorial Health Institute, Warsaw, Poland.
Pediatric Nephrology (Berlin, Germany)
|February 1, 1997
Summary
Children with a history of infantile hypercalcaemia show persistent hypercalciuria and elevated vitamin D3 metabolites, suggesting a primary metabolic defect. This condition may lead to silent nephrocalcinosis, requiring further investigation.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Nephrology
Background:
- Idiopathic infantile hypercalcaemia (IIH) is a rare condition.
- Mild forms of IIH may persist into childhood.
- Long-term consequences of IIH on calcium-phosphate and vitamin D3 metabolism are not fully understood.
Purpose of the Study:
- To characterize calcium-phosphate and vitamin D3 metabolism abnormalities in children with a history of mild IIH.
- To investigate persistent hypercalciuria and nephrocalcinosis in these children.
Main Methods:
- Studied 17 children (2-12 years) with a history of IIH.
- Included two reference groups: vitamin D3 intoxication and Williams syndrome.
- Measured urinary calcium excretion, serum 25-hydroxyvitamin D3, and 1,25-dihydroxyvitamin D3 levels.
- Utilized ultrasound for nephrocalcinosis detection.
Main Results:
- Children with IIH history exhibited significant hypercalciuria compared to reference groups.
- Elevated serum 25-hydroxyvitamin D3 levels were observed in the study group.
- 1,25-dihydroxyvitamin D3 levels were at the upper limit of normal.
- Clinically silent nephrocalcinosis was detected via ultrasound.
Conclusions:
- Disturbances in vitamin D3 and calcium-phosphate metabolism persist in the normocalcemic phase of IIH.
- These persistent abnormalities may represent a primary metabolic defect.
- Further research is needed to elucidate the mechanisms of elevated vitamin D3 metabolites, hypercalciuria, and nephrocalcinosis in IIH.